Omega Funds, the biotech VC firm founded by brash investor Otello Stampacchia, has raised nearly $650 million to invest in ...

The Food and Drug Administration on Monday named George Tidmarsh, a longtime biotech executive who has a background in ...

Alkermes’ investigational drug helped people with a type of narcolepsy stay awake during the day in a mid-stage trial.

University of Minnesota president Rebecca Cunningham is drawing on her experience as an emergency physician in this ...

You know you’re going to die, right?” When Joy Lisi Rankin’s mother decided not to treat her breast cancer, doctors were ...

Sarepta Therapeutics refused a FDA request to halt shipments of Elevidys, its gene therapy for Duchenne muscular dystrophy ...

On Friday, Congressional Republicans passed legislation to take back money they’d already appropriated this year, enacting steep cuts to foreign aid and public broadcasting. It doesn’t sound like it’s ...

ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...

Our health care system needs to do a better job of diagnosing and supporting people with cannabis-related diseases,” a ...

A 51-year-old man died last month after receiving an experimental treatment from Sarepta, the third death this year tied to ...

More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.

Getting Coca-Cola to use cane sugar rather and ice cream manufacturers to stop their use of synthetic dyes are the latest ...